Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Valeant Pharmaceuticals Intl Inc (VRX) Stock Is the Twitter Inc (TWTR) of Pharma

The air is rife with comeback stories, but Valeant Pharmaceuticals faces an obscenely difficult task in returning VRX stock to greatness.

3 Stock Picks That Are PERFECT for Millennials

Stock picks for millennials -- like FUEL, JCI and GBTC -- are supposed to be vibrant, dynamic and a bit risky because they have an enviable advantage -- time!

Alphabet Inc (GOOGL) Stock Is Still a Top Tech Stock

GOOGL stock has some fundamental and technical worries, but the overall picture is that Alphabet Inc will stand the test of time.

Has Fitbit Inc (FIT) Stock Finally Hit the Bottom?

Fitbit (FIT) endured a terrible fourth-quarter earnings report, but Fitbit stock is holding firm. The bottom might be in.

3 Vaporizer Stocks With Big Legislation Upside

Despite grumblings from Big Tobacco, vaporizers and vaporizer stocks have plenty of tailwinds, including marijuana and legislation.